Safety assessment of compounded non-FDA-approved hormonal therapy versus FDA-approved hormonal therapy in treating postmenopausal women

Overview of attention for article published in Menopause (New York, N.Y.), May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 4 news outlets
twitter: 18 X users
reddit: 4 Redditors

guideline: 1 clinical guideline source
podcasts: 1 podcast

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 21 X posts from 18 X users, with an upper bound of 53,492 followers.

Safety assessment of compounded non-FDA-approved hormonal... : Menopause https://t.co/ZBX8LurX83

RT @SabrinaDareCEO: This study on #hormonetherapy speaks to the importance of Food and Drug Administration approved Hormonal Therapy versus…

An important study by one of my smartest colleagues!!

RT @MenopauseJrnl: Editor’s Pick: Safety Assessment of Compounded Non-FDA approved #HormonalTherapy vs. FDA approved Hormonal Therapy in Tr…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 17 additional X posts.